1,2-Dichloroethane → ((R)-5-{3-Bromo-5-[(5-bromo-pyrimidine-2-carbonyl)-amino]-phenyl}-5-methyl-5,6-dihydro-2H-[1,4]oxazin-3-yl)-carbamic acid tert-butyl ester

HRID 2196250Notes

Reaction equation

HRID 2196250 reaction equation
[C:1]([O:5][C:6](=[O:23])[NH:7][C:8]1[CH2:9][O:10][CH2:11][C@:12]([C:15]2[CH:20]=[C:19]([Br:21])[CH:18]=[C:17]([NH2:22])[CH:16]=2)([CH3:14])[N:13]=1)([CH3:4])([CH3:3])[CH3:2].[Br:24][C:25]1[CH:26]=[N:27][C:28]([C:31](O)=[O:32])=[N:29][CH:30]=1.C1C=CC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C.C(Cl)CCl>ClCCl>[C:1]([O:5][C:6](=[O:23])[NH:7][C:8]1[CH2:9][O:10][CH2:11][C@:12]([C:15]2[CH:16]=[C:17]([NH:22][C:31]([C:28]3[N:29]=[CH:30][C:25]([Br:24])=[CH:26][N:27]=3)=[O:32])[CH:18]=[C:19]([Br:21])[CH:20]=2)([CH3:14])[N:13]=1)([CH3:2])([CH3:3])[CH3:4]

Participants

7

Conditions

Temperature
0 °C

Procedure

[(R)-5-(3-Amino-5-bromo-phenyl)-5-methyl-5,6-dihydro-2H-[1,4]oxazin-3-yl]-carbamic acid tert-butyl ester (33 mg, 0.082 mmol), 5-bromo-pyrimidine-2-carboxylic acid (18 mg, 0.090 mmol) and HOBT (16 mg, 0.106 mmol) were dissolved in dichloromethane under N2 at 0° C. DIPEA (10.54 mg, 0.082 mmol) and EDC (17 mg, 0.090 mmol) were added. The mixture was stirred at 0° C. for 10 min, then allowed to warm to room temperature, stirred for 17 h at room temperature, quenched with 1M aqueous KHCO3 solution and extracted with dichloromethane. The organic phase was washed with water and brine, dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by automated column chromatography (cyclohexane/ethyl acetate) to yield the title compound as a tan foam. MS: 569 [(M+H)+].

Workup

  1. temperatureto warm to room temperature
  2. stirringstirred for 17 h at room temperature
  3. customquenched with 1M aqueous KHCO3 solution
  4. extractionextracted with dichloromethane
  5. washThe organic phase was washed with water and brine
  6. dry with materialdried over Na2SO4
  7. concentrationconcentrated under reduced pressure
  8. customThe residue was purified by automated column chromatography (cyclohexane/ethyl acetate)

Sources & evidence

ORD record
ord-603d1186fed94ba3bae9c7e76c92e032
Source dataset
uspto-grants-2012_12
Patent number
US08338413B1

Reaction notes

Loading…